# Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy

> **NCT06005610** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 93 (actual)

## Conditions studied

- HIV I Infection

## Interventions

- **DRUG:** Estradiol

## Key facts

- **NCT ID:** NCT06005610
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-01-04
- **Primary completion:** 2025-08-21
- **Final completion:** 2025-08-21
- **Target enrollment:** 93 (ACTUAL)
- **Why stopped:** Trial terminated by Sponsor.
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005610, "Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06005610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*